Skip to main content
. 2010 May 18;12(9):991–1003. doi: 10.1093/neuonc/noq050

Table 1.

Clinicobiological characteristics of glioma patients and their corresponding tumors analyzed by both interphase FISH and DNA oligonucleotide expression arrays (n = 40)

Case ID Histology WHO grade Ancestral tumor cell clone Age Gender Karnofsky index (%) Patient status Overall survival (months)b
1 Pilocytic astrocytoma I Tetraploidy 21 F 80 Alive 24
2 Pilocytic astrocytoma I Tetraploidy 50 F 90 Alive 22
3 Pilocytic astrocytoma I +7+10q 34 F 90 Alive 10
4 Difuse astrocytoma II +7p 67 F 70 Dead 11
5 Difuse astrocytoma II Tetraploidy 38 M 90 Alive 27
6 Anaplastic astrocytoma III +7+10q 30 M 80 Dead 4
7 Anaplastic astrocytoma III Tetraploidy 27 M 90 Alive 28
8 GBM IV Amp 7p 67 F 60 Dead 15
9 GBM IV Amp 7p 50 F 80 Dead 13
10 GBM IV Amp 7p 71 F 60 Dead 8
11 GBM IV Amp 7p 70 M 80 Alive 18
12a GBM IV Amp 7p 70 F 70 Alive 17
13a GBM IV Amp 7p 45 F 60 Alive 15
14 GBM IV Amp 7p 48 M 90 Dead 13
15 GBM IV Amp 7p 74 M 60 Alive 8
16 GBM IV +7 69 F 60 Dead 1
17 GBM IV +7 79 M 80 Dead 4
18 GBM IV +7 62 M 60 Dead 3
19 GBM IV +7 67 M 60 Dead 2
20a GBM IV +7q 70 F 80 Dead 18
21 GBM IV +7q 35 F 80 Dead 14
22a GBM IV +7q 39 F 80 Dead 19
23a GBM IV +7p 30 F 80 Alive 62
24 GBM IV +7p 69 M 60 Dead 5
25 GBM IV −9p 67 F 70 Dead 9
26 GBM IV −9p 50 F 50 Dead 2
27 GBM IV −9p 73 M 70 Dead 2
28 GBM IV +7p–9p 66 M 80 Dead 25
29 GBM IV +7p–9p 74 M 70 Dead 1
30 GBM IV +7p–9p 84 M 70 Alive 10
31 GBM IV +7p–9p 56 M 80 Alive 8
32 GBM IV −10q 76 F 60 Alive 11
33 GBM IV −10q 60 M 60 Dead 2
34 Gliosarcoma IV +17p+19q 59 M 70 Dead 8
35a Gliosarcoma IV +7+10q+17p 39 M 80 Dead 21
36 OL II −1p−19q 37 M 90 Alive 11
37 AO III −9 64 M 70 Dead 5
38 AO III +7p–9p 53 M 70 Alive 11
39 Mixed AOA III +7–9p 81 F 70 Dead 3
40a Mixed AOA III −9p 65 M 70 Alive 17

Abbreviations: FISH, fluorescence in situ hybridization; F, female; M, male; GBM, glioblastoma multiforme; OL, oliodendroglioma; AO, anaplastic oligodendroglioma; AOA, anaplastic oligoastrocytoma.

aRecurrent tumor.

bOverall survival defined from diagnosis to the last visit or date of death.